Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-08 |
mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-08 |
mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-08 |
mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-08 |
mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.28 | 5e-08 |
mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.2 | 6e-08 |
mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.2 | 8e-08 |
mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-07 |
mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-07 |
mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-07 |